Does adjuvant chemotherapy for t1 node-positive colon cancers provide significant survival benefit?
Limitations include potential selection bias as well as the inability to compare disease-free survival/recurrence.
Our results indicate that luxS-based AI-2 communication is associated with antibiotic susceptibility. Targeting the AI-2 signal communication may present a novel approach in antimicrobial therapy.